Skip to content
Screener

BioLife Solutions BLFS Q2 2025 earnings

Reported August 7, 2025 · After market close

Revenue$25.4MMiss by $269.6K
EPS-$0.33Miss by $0.30
Revenue estimate$25.7M
EPS estimate-$0.03

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$29.2M
EPS estimate$0.01

Financials

Q2 2025

Income statement

See full
Revenue$23.4M+18.9%
Gross profit$15.2M+21.6%
Operating income-$16.1M-1,135%
Net income-$15.8M+23.6%
EPS (diluted)-$0.33+26.7%

Balance sheet

See full
Cash & equivalents$31.9M+44.7%
Total debt$23.8M-33.8%
Total equity$347.2M+8.0%
Total assets$387.2M+3.3%

Cash flow

See full
Operating cash flow$7.4M+14.1%
CapEx$1.7M+532%
Free cash flow$5.6M-9.0%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$1.04B+5.0%
Enterprise value$1.03B+2.8%
P/S12.6×—

Profitability

See full
Gross margin67.2%—

Returns & leverage

See full
Debt / equity0.1×0.0×
Current ratio4.4×+1.6×

FAQ

When did BioLife Solutions report Q2 2025 earnings?
BioLife Solutions (BLFS) reported Q2 2025 earnings on August 7, 2025 after market close.
What were BioLife Solutions's Q2 2025 revenue and EPS?
BioLife Solutions reported revenue of $25.4M and eps of $-0.33 for Q2 2025.
Did BioLife Solutions beat estimates in Q2 2025?
Revenue missed the consensus estimate of $25.7M by $269.6K. EPS missed the consensus estimate of $-0.03 by $0.30.
How did BioLife Solutions's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 28.9% from $19.7M a year earlier and eps declined 452.3% from $-0.06.
Where can I find BioLife Solutions's Q2 2025 SEC filings?
You can read the 8-K earnings release (0000834365-25-000014) and the 10-Q periodic report (0000834365-25-000016) directly on SEC EDGAR. The filing index links above go to sec.gov.